Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis

OBJECTIVE: The association between the use of renin–angiotensin–aldosterone (RAAS) inhibitors and the risk of mortality from COVID-19 is unclear. We aimed to estimate the association of RAAS inhibitors, including ACE inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) with COVID-19 mortali...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Open Heart
Asıl Yazarlar: Ssentongo, Anna E, Ssentongo, Paddy, Heilbrunn, Emily S, Lekoubou, Alain, Du, Ping, Liao, Duanping, Oh, John S, Chinchilli, Vernon M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2020
Konular:
Meta-Analysis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646321/
https://ncbi.nlm.nih.gov/pubmed/33154144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2020-001353
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller